Maria Lucibello - Concepedia

Concepedia

Author

Maria Lucibello

University of Rome Tor Vergata ORCID

Also Known As

E. Garaci, M Lucibello, Maria Lucibello

24

Publications

1.4K

Citations

15

H-Index

46

Concepts

All Affiliations

University of Rome Tor Vergata National Research Council University of Florence Istituto di Farmacologia Traslazionale National Academies of Sciences, Engineering, and Medicine

ML

About

Maria Lucibello is an author at University of Rome Tor Vergata specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	756
2	Cell Biology	6	6	619
3	Health Sciences	1	1	89
4	Social Sciences	1	1	396
5	Allergy	1	1	89

Maria Lucibello

×

16

Publications

1.4K

Citations

15

H-Index

	Year	Citations
Nerve Growth Factor Is an Autocrine Survival Factor for Memory B Lymphocytes Maria Gabriella Torcia, Luisa Bracci‐Laudiero, Maria Lucibello, Cell Autoimmune DiseaseMedicineImmunologyNerve Growth FactorMemory	1996	396
Bcl-2 Phosphorylation by p38 MAPK Giovanna De Chiara, Maria Elena Marcocci, Maria Gabriella Torcia, Journal of Biological Chemistry	2006	196
Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to <i>Plasmodium falciparum</i> malaria Maria Gabriella Torcia, Veronica Santarlasci, Lorenzo Cosmi, Proceedings of the National Academy of Sciences GeneticsMalariaImmune RegulationImmunologyPathology	2008	137
Nerve Growth Factor Inhibits Apoptosis in Memory B Lymphocytes via Inactivation of p38 MAPK, Prevention of Bcl-2 Phosphorylation, and Cytochrome c Release Maria Gabriella Torcia, Giovanna De Chiara, Lucia Nencioni, Journal of Biological Chemistry	2001	119
Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. F Cozzolino, Maria Gabriella Torcia, Maria Lucibello, Journal of Clinical Investigation Endothelial Cell GrowthImmunologyCell CultureCell ProliferationInflammation	1993	89
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells Maria Lucibello, Sara Adanti, Dario Dezi, Oncotarget	2015	60
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death Maria Lucibello, Alessandra Gambacurta, Manuela Zonfrillo, Experimental Cell Research Reductive StressTumor BiologyMedicineApoptosisCritical Survival Factor	2011	57
Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Maria Gabriella Torcia, Maria Lucibello, Edouard Vannier, Cineca Institutional Research Information System (Tor Vergata University)	1996	48
The Cystine/Cysteine Cycle and GSH Are Independent and Crucial Antioxidant Systems in Malignant Melanoma Cells and Represent Druggable Targets Roberta Venè, Patrizia Castellani, Laura Delfino, Antioxidants and Redox Signaling	2011	46
Androgen receptor expression induces FGF2, FGF‐binding protein production, and FGF2 release in prostate carcinoma cells: Role of FGF2 in growth, survival, and androgen receptor down‐modulation Paolo Rosini, Lorella Bonaccorsi, Elisabetta Baldi, The Prostate	2002	45

Page 1